Literature DB >> 26493522

Depression and the Suicidal Patient.

Dick C Kuo1, Mina Tran2, Asim A Shah3, Anu Matorin3.   

Abstract

Depression is the most common psychiatric illness in the general community, with 3% to 4% of depressives dying by suicide today. Studies have shown that depression has considerable morbidity and mortality. This article focuses on depressed patients and their management within the emergency department. Understanding the intricacies of the interview process and identifying which patients need immediate attention are important skills for the emergency physician.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Depression; Emergency room; Suicide; Suicide risk

Mesh：

Year:  2015        PMID： 26493522     DOI： 10.1016/j.emc.2015.07.005

Source DB:  PubMed          Journal:  Emerg Med Clin North Am        ISSN： 0733-8627            Impact factor:   2.264


  7 in total

1.  Increased risk of depression in patients with acquired sensory hearing loss: A 12-year follow-up study.

Authors:  Wei-Ting Hsu; Chih-Chao Hsu; Ming-Hsun Wen; Hong-Ching Lin; Hsun-Tien Tsai; Peijen Su; Chi-Te Sun; Cheng-Li Lin; Chung-Yi Hsu; Kuang-Hsi Chang; Yi-Chao Hsu
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

2.  Kososan, a Kampo medicine, prevents a social avoidance behavior and attenuates neuroinflammation in socially defeated mice.

Authors:  Naoki Ito; Eiji Hirose; Tatsuya Ishida; Atsushi Hori; Takayuki Nagai; Yoshinori Kobayashi; Hiroaki Kiyohara; Tetsuro Oikawa; Toshihiko Hanawa; Hiroshi Odaguchi
Journal:  J Neuroinflammation       Date:  2017-05-03       Impact factor: 8.322

Review 3.  Prevalence of depression and depressive symptoms among outpatients: a systematic review and meta-analysis.

Authors:  Jinghui Wang; Xiaohang Wu; Weiyi Lai; Erping Long; Xiayin Zhang; Wangting Li; Yi Zhu; Chuan Chen; Xiaojian Zhong; Zhenzhen Liu; Dongni Wang; Haotian Lin
Journal:  BMJ Open       Date:  2017-08-23       Impact factor: 2.692

4.  Attachment-based compassion therapy and adapted mindfulness-based stress reduction for the treatment of depressive, anxious and adjustment disorders in mental health settings: a randomised controlled clinical trial protocol.

Authors:  Jesus Montero-Marin; Carlos Collado-Navarro; Mayte Navarro-Gil; Alba Lopez-Montoyo; Marcelo Demarzo; Paola Herrera-Mercadal; Alberto Barcelo-Soler; Javier Garcia-Campayo
Journal:  BMJ Open       Date:  2019-10-08       Impact factor: 2.692

Review 5.  Evaluation of Android and Apple Store Depression Applications Based on Mobile Application Rating Scale.

Authors:  Jaime Martín-Martín; Antonio Muro-Culebras; Cristina Roldán-Jiménez; Adrian Escriche-Escuder; Irene De-Torres; Manuel González-Sánchez; María Ruiz-Muñoz; Fermín Mayoral-Cleries; Attila Biró; Wen Tang; Borjanka Nikolova; Alfredo Salvatore; Antonio Cuesta-Vargas
Journal:  Int J Environ Res Public Health       Date:  2021-11-27       Impact factor: 3.390

6.  The Effects of Iron Oxide Nanoparticles Administration on Depression Symptoms Induced by LPS in Male Wistar Rats.

Authors:  Fatemeh Saeidienik; Mohammad Reza Shahraki; Hamed Fanaei; Fereshteh Badini
Journal:  Basic Clin Neurosci       Date:  2018 May-Jun

Review 7.  Global Burden of Anxiety and Depression among Cystic Fibrosis Patient: Systematic Review and Meta-Analysis.

Authors:  Mistire Teshome Guta; Tiwabwork Tekalign; Nefsu Awoke; Robera Olana Fite; Getahun Dendir; Tsegaye Lolaso Lenjebo
Journal:  Int J Chronic Dis       Date:  2021-07-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.